After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine (Published 2020)

Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have eroded confidence. The announcement this week that a cheap, easy-to-make coronavirus vaccine appeared to be up to 90 percent effective was greeted with jubilation. “Get …